Se trataron los siguientes artículos en el mes de Mayo de 2016:
– Atezolizumab in patients with locally advanced and metastasic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial (Presentado por Sanatorio Aconcagua)
*Link para ver el artículo: Click aquí
– A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastasic breast cancer (UCBG 12-1) (Presentado por Sanatorio Aconcagua)
*Link para ver el artículo: Click aquí
– Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients with Chemotherapy-Refractory Advanced or Metastasic Adenocarcinoma of the Stomach or Gastroesophageal Junction (Presentado por Hospital Privado)
*Link para ver el artículo: Click aquí
– Evaluation of Immune-Related Response Criteria and RECIST v1.1 in Patients With Advanced Melanoma Treated With Pembrolizumab (Presentado por Hospital Privado)
*Link para ver el artículo: Click aquí
– Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials (Presentado por Centro Médico Deán Funes)
*Link para ver el artículo: Click aquí
– Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patiens with Locally Advanced Pancreatic Cancer Controlled after 4 Months of Gemcitabine with or without Erlotinib: The LAP07 Randomized Clinical Trial (Presentado por Centro Médico Deán Funes)
*Link para ver el artículo: Click aquí
